Back to Journals » ClinicoEconomics and Outcomes Research » Volume 16

Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Total article views   HTML views PDF downloads Totals
2,334 Dovepress* 2,266+ 51 2,317
PubMed Central* 68 42 110
Totals 2,334 93 2,427
*Since 11 April 2024
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 1 4

View citations on PubMed and Google Scholar